Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PAAR is a private London-based health and longevity company that provides personalized, preventive wellness programs rather than a traditional drug-development pipeline. The company combines advanced diagnostics, functional and integrative health assessment, expert consultations, and AI-supported care planning to deliver individualized programs focused on longevity, vitality, and root-cause wellness. Its offerings include broad longevity programs and targeted health programs addressing areas such as gut health, hormonal balance, weight management, detoxification, metabolism, and pregnancy support. PAAR also offers a portfolio of diagnostic services including microbiome, hormonal, blood, genetic, epigenetic, and heavy-metal testing. The business appears to operate as a commercial healthcare and digital-health services company, not as a biotech or pharmaceutical developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PAAR.